Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006

Area of Science:

• Epidemiology
• Infectious Diseases
• Public Health

Background:

• Human immunodeficiency virus (HIV) infection remains a significant global health concern.
• Coinfection with hepatitis C virus (HCV) is common among HIV-positive individuals, particularly those with a history of injection drug use.
• Understanding trends in transmission routes is crucial for effective prevention and control strategies.

Purpose of the Study:

• To analyze the changes in prevalence of injection drug use among Spanish HIV patients from 1997 to 2006.
• To assess the parallel trends in HCV coinfection during the same period.
• To investigate the impact of evolving HIV transmission routes on these prevalence changes.

Main Methods:

• Retrospective analysis of patient data from Spain.
• Prevalence calculations for injection drug use and HCV coinfection at two time points (1997 and 2006).
• Correlation analysis between transmission routes and coinfection rates.

Main Results:

• Prevalence of injection drug use among Spanish HIV patients decreased from 67.3% in 1997 to 14.5% in 2006.
• HCV coinfection prevalence among these patients dropped from 73.8% in 1997 to 19.8% in 2006.
• A significant shift in HIV transmission routes was identified as the primary driver for the decline in coinfection.

Conclusions:

• The study demonstrates a substantial decrease in injection drug use and associated HCV coinfection among Spanish HIV patients over a decade.
• Changes in the primary modes of HIV transmission have played a critical role in reducing coinfection rates.
• Public health interventions and evolving epidemiological patterns have likely contributed to these favorable trends.